NasdaqCM - Delayed Quote USD

Pulse Biosciences, Inc. (PLSE)

6.85 -0.34 (-4.73%)
At close: April 22 at 4:00 PM EDT
6.85 0.00 (0.00%)
After hours: April 22 at 4:01 PM EDT
Loading Chart for PLSE
DELL
  • Previous Close 7.19
  • Open 7.30
  • Bid 6.79 x 300
  • Ask 6.88 x 400
  • Day's Range 6.73 - 7.30
  • 52 Week Range 3.78 - 13.62
  • Volume 93,268
  • Avg. Volume 170,541
  • Market Cap (intraday) 378.293M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.88
  • Earnings Date May 9, 2024 - May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

www.pulsebiosciences.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PLSE

Q4 2023 Pulse Biosciences Inc Earnings Call

Performance Overview: PLSE

Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PLSE
44.04%
S&P 500
5.05%

1-Year Return

PLSE
15.71%
S&P 500
21.22%

3-Year Return

PLSE
66.59%
S&P 500
20.06%

5-Year Return

PLSE
56.03%
S&P 500
72.48%

Compare To: PLSE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PLSE

Valuation Measures

Annual
As of 4/22/2024
  • Market Cap

    377.74M

  • Enterprise Value

    342.52M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    8.52

  • Enterprise Value/Revenue

    -48.75k

  • Enterprise Value/EBITDA

    -8.08

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -39.75%

  • Return on Equity (ttm)

    -200.46%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -42.21M

  • Diluted EPS (ttm)

    -0.88

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    44.37M

  • Total Debt/Equity (mrq)

    20.61%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: PLSE

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: PLSE

Fair Value

6.85 Current
 

Dividend Score

0 Low
PLSE
Sector Avg.
100 High
 

Hiring Score

0 Low
PLSE
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
PLSE
Sector Avg.
100 High
 

Research Reports: PLSE

  • Daily – Vickers Top Insider Picks for 02/16/2024

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 02/15/2024

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 02/14/2024

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 02/13/2024

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     

People Also Watch